Compare CLPT & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPT | OFIX |
|---|---|---|
| Founded | 1998 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.6M | 500.2M |
| IPO Year | 2009 | 1998 |
| Metric | CLPT | OFIX |
|---|---|---|
| Price | $9.62 | $11.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $22.50 | $17.25 |
| AVG Volume (30 Days) | ★ 940.5K | 286.4K |
| Earning Date | 03-17-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | $36,971,000.00 | ★ $822,312,000.00 |
| Revenue This Year | $53.12 | $6.32 |
| Revenue Next Year | $32.97 | $6.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.78 | 2.85 |
| 52 Week Low | $8.63 | $10.25 |
| 52 Week High | $30.10 | $17.00 |
| Indicator | CLPT | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 36.39 | 36.03 |
| Support Level | $8.63 | $10.55 |
| Resistance Level | $11.74 | $16.38 |
| Average True Range (ATR) | 0.82 | 0.43 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 25.69 | 15.38 |
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.